The embryonic stem cell test for the early selection of pharmaceutical compounds (Q79954976)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

The embryonic stem cell test for the early selection of pharmaceutical compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sonia Whitlow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Heinrich Bürgin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nicole Clemann

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

ALTEX: Alternatives to Animal Experimentation

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

3-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods

27 December 2019

cites work

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Embryonic stem cells: prospects for developmental biology and cell therapy

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

The stem-cell test—A novel in vitro assay for teratogenic potential

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Prevalidation of the Embryonic Stem Cell Test (EST)-A New In Vitro Embryotoxicity Test

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Co-culture of rat embryos and hepatocytes: in vitro detection of a proteratogen

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: A new approach to in vitro teratogenesis screening

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Validation of alternative methods for developmental toxicity testing

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Biotransformation of cyclophosphamide in post-implantation rat embryo culture using maternal hepatocytes in co-culture

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent

1 reference

15 October 2024

https://opencitations.net/index/api/v1/references/10.14573/ALTEX.2007.1.3

Identifiers

DOI

10.14573/ALTEX.2007.1.3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361315%20AND%20SRC:MED&resulttype=core&format=json